RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

MedImmune Inc.

A collection of news and information related to MedImmune Inc. published by this site and its partners.

Top MedImmune Inc. Articles see all

Displaying items 1-5
  • Oracle to buy Columbia's Micros Systems in $5.3 billion deal

    Oracle to buy Columbia's Micros Systems in $5.3 billion deal
    Silicon Valley giant Oracle Corp. plans to acquire Columbia-based Micros Systems Inc. for $5.3 billion in a deal executives and industry observers said could generate local job growth instead of the typical corporate consolidation.
  • MedImmune expands research with universities

    MedImmune expands research with universities
    Biotechnology company MedImmune said Tuesday it has expanded a bioresearch collaboration it started with the University of System of Maryland. The Gaithersburg company, a development arm of AstraZeneca, started the partnership with the University of...

    A plan for building Maryland's economy [Commentary]

    A plan for building Maryland's economy [Commentary]
    Earlier this General Assembly session, we joined together to announce a transformational economic development commission, a part of a joint economic development agenda that builds on the strategic investments Gov. Martin O'Malley and the legislature...

    U.Md. program awards $4.1 million to companies and faculty developing tech products

    U.Md. program awards $4.1 million to companies and faculty developing tech products
    A University of Maryland program that matches researchers with companies has awarded $4.1 million to 15 teams working to bring technology products to market. Baltimore-area companies that will work with faculty through the Maryland Industrial...

    Pfizer walks away from AstraZeneca takeover attempt

    Pfizer walks away from AstraZeneca takeover attempt
    Pfizer Inc. said Monday that it had abandoned its current attempt to buy AstraZeneca PLC for nearly $118 billion — a deal watched warily by Maryland officials — as a deadline approached without a last-minute change of heart by the British...